Eosinophilic esophagitis: A clinicopathological review

Hamish Philpott, Sanjay Nandurkar, Francis Thien, Peter R. Gibson, Simon G. Royce

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)


Eosinophilic esophagitis (EoE) is considered to be a chronic antigen-driven disease whereby food and/or aeroallergens induce a chronic inflammatory infiltrate in the esophagus, resulting in pathological hyperplasia of the epithelia and muscular layers, and fibrosis of the lamina propria (referred to collectively as remodelling) and the symptoms of dysphagia and food impaction. EoE shares features with other atopic conditions of asthma and atopic dermatitis, such as a TH2 cytokine milieu and a mixed inflammatory infiltrate of eosinophils, mast cells and lymphocytes. Relatively distinct features include the strong male predominance amongst adult patients, and the expression of the eosinophil chemokine eotaxin 3. Current first line treatments such as strict dietary modification and corticosteroids fail many patients. Looking forward, clarification of distinct genotype/phenotype associations, determining the reversibility of remodelling following treatment, and the development of new pharmacotherapies that target fibrotic pathways (as opposed to eosinophilic inflammation per se) or specifically improve barrier integrity appear relevant.

Original languageEnglish
Pages (from-to)12 - 22
Number of pages11
JournalPharmacology & Therapeutics
Publication statusPublished - 2015


  • Allergy
  • Diet
  • Dysphagia
  • Eosinophil
  • Esophagitis
  • Remodelling

Cite this